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Abstract
Increased O2 metabolism resulting in chronic hypoxia is common in models of endstage renal disease. Mitochondrial
uncoupling increases O2 consumption but the ensuing reduction in mitochondrial membrane potential may limit excessive
oxidative stress. The present study addressed the hypothesis that mitochondrial uncoupling regulates mitochondria
function and oxidative stress in the diabetic kidney. Isolated mitochondria from kidney cortex of control and streptozotocin-
induced diabetic rats were studied before and after siRNA knockdown of uncoupling protein-2 (UCP-2). Diabetes resulted in
increased UCP-2 protein expression and UCP-2-mediated uncoupling, but normal mitochondria membrane potential. This
uncoupling was inhibited by GDP, which also increased the membrane potential. siRNA reduced UCP-2 protein expression
in controls and diabetics (230–50%), but paradoxically further increased uncoupling and markedly reduced the membrane
potential. This siRNA mediated uncoupling was unaffected by GDP but was blocked by ADP and carboxyatractylate (CAT).
Mitochondria membrane potential after UCP-2 siRNA was unaffected by GDP but increased by CAT. This demonstrated that
further increased mitochondria uncoupling after siRNA towards UCP-2 is mediated through the adenine nucleotide
transporter (ANT). The increased oxidative stress in the diabetic kidney, manifested as increased thiobarbituric acids, was
reduced by knocking down UCP-2 whereas whole-body oxidative stress, manifested as increased circulating
malondialdehyde, remained unaffected. All parameters investigated were unaffected by scrambled siRNA. In conclusion,
mitochondrial uncoupling via UCP-2 regulates mitochondria membrane potential in diabetes. However, blockade of the
diabetes-induced upregulation of UCP- 2 results in excessive uncoupling and reduced oxidative stress in the kidney via
activation of ANT.
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Introduction
The prevalence of diabetic nephropathy is increasing rapidly
world-wide [1], but presently there is no treatment and
approximately 45% of all cases of end-stage renal disease are
due to diabetic nephropathy [2]. The recent focus of mechanisms
underlying diabetic nephropathy has shifted from the glomerulus
to the proximal tubule [3]. The kidney proximal tubule performs
a majority of the active transport in the kidney, which requires
a high ATP production and a high cellular content of mitochon-
dria. The ensuing high rate of oxidative phosphorylation is
a potential source of superoxide radicals since an estimated 0.1–
0.2% of the mitochondrial O2 usage results in superoxide
formation. Increased passage of electrons down the respiratory
chain increases the mitochondria membrane potential and
therefore also formation of superoxide [4].
Mitochondria uncoupling may be a protective mechanism to
counter increased mitochondria superoxide formation. Shunting
of protons across the inner mitochondrial membrane lowers the
membrane potential and limits superoxide formation. However,
O2 consumption required for proton transport uncoupled from
ATP production will be added to that required for oxidative
phosphorylation and therefore increases total O2 consumption.
The level of mitochondria uncoupling can be evaluated in isolated
mitochondria during ATP-synthase inhibition [5]. Then, the
addition of electron-donating substrates such as glutamate can
increase O2 consumption only if an uncoupling mechanism is
present. This is denoted as glutamate-stimulated O2 consumption
of isolated mitochondria in the present study. There are five
different isoforms of uncoupling proteins (UCP) known to mediate
mitochondria uncoupling [6], but UCP-2 is the isoform expressed
in both rat and human kidneys [5,7] where it is reported to
mediate mitochondria uncoupling in the diabetic kidney [5].
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e39635Whereas reduced superoxide formation, via mitochondria uncou-
pling, may protect the diabetic kidney from damaging oxidative
stress, the concomitantly increased O2 consumption may result in
hypoxia and contribute to the development of diabetic nephrop-
athy. Indeed, kidney tissue hypoxia in diabetes has been reported
[8]. The present study investigates the role of UCP-2 in the
regulation of mitochondria function and oxidative stress in the
diabetic kidney by applying in vivo siRNA-mediated knockdown of
UCP-2.
Results
UCP-2 protein expression was increased in the kidneys of
diabetic rats but siRNA resulted in 230% decreased expression
compared to baseline in control animals and 255% compared to
baseline in diabetic animals. Scrambled siRNA did not signifi-
cantly alter UCP-2 protein expression in any of the groups
compared to corresponding untreated animals (Fig. 1). Diabetic
animals displayed increased blood glucose levels compared to
control animals. siRNA did not affect either blood glucose levels or
body weights (Table 1). Diabetic animals administered UCP-2
siRNA displayed increased state 4 respiration compared to
untreated controls, whereas scramble siRNA had no effect. State
3 respiration and RCR of isolated mitochondria did not differ
between any of the groups (Fig. 2).
Mitochondria glutamate-stimulated O2 consumption was in-
creased in mitochondria isolated from the kidneys of untreated
diabetic rats compared to corresponding controls. UCP-2 siRNA,
but not scrambled siRNA, increased glutamate-stimulated O2
consumption in both controls and diabetics. GDP inhibited
glutamate-stimulated O2 consumption in untreated diabetics and
diabetic animals receiving scrambled siRNA. No effect of GDP
was observed in any of the control groups (Fig. 3). ADP inhibited
glutamate-stimulated O2 consumption in mitochondria isolated
from diabetic animals treated with UCP-2 siRNA, but had no
effect in any of the other groups (Fig. 4). CAT inhibited glutamate-
stimulated O2 consumption in both control and diabetic animals
treated with UCP-2 siRNA, but did not affect glutamate-
stimulated O2 consumption in any of the untreated animals or
animals treated with scrambled siRNA (Fig. 5).
Baseline TMRM-uptake in presence of oligomycin was similar
in all control groups and untreated diabetics. Baseline TMRM-
uptake was lower in diabetic animals treated with UCP-2 siRNA
compared to all other groups. GDP increased TMRM-uptake in
untreated diabetic animals, but had no effect in any of the other
groups. Furthermore, CAT increased TMRM-uptake in UCP-2
siRNA-treated diabetic animals whereas CAT had no effect in any
of the other groups (Fig. 6).
Figure 1. UCP-2 protein expression in control and diabetic animals with and without scramble or UCP-2 siRNA administration. A
representative blot is displayed on the top.
doi:10.1371/journal.pone.0039635.g001
siRNA-Mediated Knockdown of UCP-2
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substantially lower in the presence of either FCCP, oligomycin or
the combination of oligomycin and CAT (Fig. 7).
Plasma MDA levels were elevated in untreated diabetic animals
compared to controls but unaffected by UCP-2 siRNA (Fig. 8).
TBARS in kidney cortex was increased in untreated diabetics, but
decreased in the diabetic animals administered UCP-2 siRNA.
Neither UCP-2 siRNA to controls nor scrambled siRNA to any of
the groups altered kidney tissue TBARS (Fig. 9).
Discussion
The main new finding from the present study was that
mitochondria uncoupling directly can regulate mitochondria
membrane potential and oxidative stress in the diabetic kidney.
Baseline mitochondria uncoupling in the diabetic kidney was
evident as increased UCP-2 expression, glutamate-stimulated O2
consumption and increased mitochondria membrane potential
Figure 2. Mitochondria oxygen consumption measurements A) during state 4 (filled bars) and state 3 (patterned bars) in control
and diabetic animals with and without scrambled or UCP-2 siRNA. B) Respiratory control ratio (state 3/state 4 respiration) in control and
diabetic animals with and without scrambled or UCP-2 siRNA.
doi:10.1371/journal.pone.0039635.g002
Table 1. Blood glucose and body weight in control and
diabetic animals with and without siRNA administration.
Body weight (g) Blood glucose (mmol/l)
Control 34967 4.860.1
Control+scrl siRNA 322612 4.960.4
Control+UCP-2 siRNA 30467 5.760.5
Diabetes 27868 20.161.2*
Diabetes+scrl siRNA 29669 20.961.2*
Diabetes+UCP-2 siRNA 307613 22.961.1*
*denotes p,0.05 vs. untreated control animals.
doi:10.1371/journal.pone.0039635.t001
siRNA-Mediated Knockdown of UCP-2
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previous report [5]. However, UCP-2 knockdown in diabetic
animals resulted in a paradoxical increase in uncoupling evidenced
by increased glutamate-stimulated O2 consumption. This was
a distinct uncoupling pathway since it was unaffected by blockade
of UCP-2 with GDP. Since this increased uncoupling after siRNA
to UCP-2 was inhibited by blockade of the ANT with ADP or
CAT, we concluded that it was mediated via the ANT. The failure
of GDP to inhibit this uncoupling excludes a role for residual
UCP-2. During normal function, ANT exchanges ADP for ATP
across the mitochondria inner membrane [9] and alters between
two conformations (c and m-conformation) as translocation
occurs. However, ANT can mediate mitochondria uncoupling
under certain conditions. The amount of mitochondrial ANT has
been reported to determine the level of basal uncoupling [10] and
uncoupling via the ANT can be induced by fatty acids [11].
It was surprising that the elevated mitochondria uncoupling in
UCP-2 siRNA-treated diabetics was inhibited by addition of ADP
after blocked ATP-synthesis since, in absence of ATP, the ANT
pathway should be inactive. However, ATP also is produced by
the citric cycle. Indeed, although mitochondria ATP production
during ATP-synthase inhibition was substantially reduced, some
ATP production remained. Presumably, this was sufficient to
exchange for ADP and induce ANT-mediated mitochondrial
uncoupling. However, the ANT may lock in c-conformation in the
presence of oligomycin and excess ADP or CAT. This would
inhibit proton leakage and reduce mitochondria uncoupling.
Moreover, in potato tuber mitochondria the ANT can import
double stranded DNA independently of ATP-synthesis i.e. un-
affected by oligomycin alone. Importantly, locking the ANT in c-
conformation with either oligomycin and ADP or CAT signifi-
cantly reduced DNA import [12]. In mitochondria isolated from
siRNA-treated diabetic rats the ANT provides a second ATP-
Figure 3. Mitochondria uncoupling measured as glutamate-stimulated O2 consumption during inhibition of the ATP-synthase with
oligomycin during baseline (filled bars) and after inhibition of UCP-2 with GDP (patterned bars) in control and diabetic animals
with and without scrambled or UCP-2 siRNA. * denotes p,0.05 vs. baseline within the group.
doi:10.1371/journal.pone.0039635.g003
Figure 4. Mitochondria uncoupling measured as glutamate-stimulated O2 consumption during inhibition of the ATP-synthase with
oligomycin during baseline (filled bars) and after inhibition of ANT with ADP (patterned bars) in control and diabetic animals with
and without scrambled or UCP-2 siRNA. * denotes p,0.05 vs. baseline within the group.
doi:10.1371/journal.pone.0039635.g004
siRNA-Mediated Knockdown of UCP-2
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tive stress. Locking the ANT in c-conformation had no effects in
untreated diabetic animals, demonstrating that ANT is not causing
the mitochondrial uncoupling in these animals.
Mitochondria uncoupling was unaffected by ADP in untreated
diabetic rats even though ADP has been reported to inhibit UCP
[13]. However, the lack of UCP-2 inhibition by ADP has
previously been reported in kidney mitochondria from diabetic
rats [5] and, to the best of our knowledge, inhibition of UCP-2-
mediated uncoupling by ADP has only been studied during
normal conditions. Therefore, future studies are needed in order
to evaluate if ADP actually can inhibit UCP-2 function in diabetic
kidney mitochondria.
UCP-2 knockdown in control animals resulted in increased
mitochondria uncoupling, which paradoxically did not result in
decreased mitochondrial membrane potential. It may be specu-
lated that glutamate (i.e. electron-donating NADH) is present in
sufficient amount to counteract relatively small changes in
uncoupling activity and therefore maintain normal membrane
potential. This speculation is supported by the results showing
increased TMRM uptake after addition of CAT to these
mitochondria.
Mitochondria membrane potential, as indicated by TMRM-
uptake, was not increased in untreated diabetic animals, which is
contrary to previous reports [14,15]. These studies were
performed on isolated mitochondria under conditions reflecting
Figure 5. Mitochondria uncoupling measured as glutamate-stimulated O2 consumption during inhibition of the ATP-synthase with
oligomycin during baseline (filled bars) and after inhibition of ANT with CAT (patterned bars) in control and diabetic animals with
and without scrambled or UCP-2 siRNA. * denotes p,0.05 vs. baseline within the group.
doi:10.1371/journal.pone.0039635.g005
Figure 6. Mitochondria membrane potential measured as TMRM-uptake before and after GDP, CAT or the combination of CAT and
GDP during baseline and inhibition of the ATP-synthase in control and diabetic animals with and without scrambled or UCP-2
siRNA. * denotes p,0.05 vs. no incubation within the group.
doi:10.1371/journal.pone.0039635.g006
siRNA-Mediated Knockdown of UCP-2
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situation of hyperglycemia and increased mitochondria substrate
load. Incubation with GDP increased membrane potential in
untreated diabetics, directly demonstrating a regulatory role of
mitochondria uncoupling via UCP-2 in the regulation of
mitochondria membrane potential. Interestingly, increased
ANT-mediated uncoupling in the UCP-2 siRNA-treated diabetics
resulted in significantly lower mitochondrial membrane potential.
Importantly, CAT increased mitochondria membrane potential in
diabetic animals administered UCP-2 siRNA, which further
supports a crucial compensatory involvement of ANT after acutely
reduced UCP-2 function.
Increased mitochondria uncoupling may be a protective mech-
anism to regulate mitochondria superoxide formation and prevent
excessive oxidative damage in the diabetic kidney [16]. Indeed, the
increased ANT-mediated uncoupling after UCP-2 knockdown
reduced oxidative stress in the diabetic kidney. However, this may
to be a kidney specific mechanism since although whole-body
oxidative stress, indicated by circulating MDA-levels was increased
in diabetes, it was not significantly reduced by siRNA to UCP-2.
The explanation for the discrepancy between kidney and whole-
body regulation of oxidative stress in diabetes may relate to specific
role of UCP-2 in the kidney. However, UCP-2 is the only isoform
in the kidney whereas in other tissues UCP-3 and other isoforms
will presumably not be affected by UCP-2 siRNA. Therefore,
Figure 7. Mitochondria ATP-production during no incubation and after oligomycin, FCCP or CAT in control and diabetic animals
without scrambled or UCP-2 siRNA. * denotes p,0.05 vs. no incubation within the group.
doi:10.1371/journal.pone.0039635.g007
Figure 8. Whole-body oxidative stress levels measured as circulating MDA levels in control and diabetic animals with and without
scrambled or UCP-2 siRNA.
doi:10.1371/journal.pone.0039635.g008
siRNA-Mediated Knockdown of UCP-2
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occur to the same extent as much in other tissues, resulting in less
effect on circulating markers of oxidative stress. Also, reactive
oxygen species are produced by several different sources and the
kidney proximal tubule is especially influenced by mitochondria-
derived superoxide formation due to its high metabolic demand. It
is therefore possible that the beneficial effect of mitochondria
uncoupling in reducing oxidative stress is more pronounced in the
kidney compared to the whole body. It seems likely that even
though oxidative stress levels are increased in diabetes mitochon-
dria uncoupling may present a mechanism to limit an even more
exaggerated oxidative stress level in the diabetic kidney.
The results from the present study confirm the importance of
mitochondria uncoupling in regulating mitochondrial oxidative
stress. Indeed, when uncoupling via UCP-2 was inhibited the
uncoupling function was rapidly and quantitatively replaced by
a nascent uncoupling via ANT. A similar compensatory
mitochondria uncoupling via ANT has been reported from
skeletal muscle mitochondria of UCP-3 knockout-mice. Two
weeks caloric restriction resulted in increased CAT-sensitive
uncoupling and it was proposed that increased ANT uncoupling
compensates for the absence of UCP-3 [17]. Furthermore, ANT is
expressed in the rat kidney [18] and is activated by fatty acids,
alkenals such as 4-hydroxynonenal [19] and AMP [20]. Oxidative
stress in diabetes increases lipid peroxidation and an enhanced free
fatty acid production would be expected to increase ANT activity.
Thus, increased ANT activation via lipid peroxidation products,
may explain the increased kidney mitochondria uncoupling after
UCP-2 siRNA. We speculate that ANT compensates for decreased
UCP-2 function to protect the mitochondria from excessive
diabetes-induced oxidative stress. Indeed, Duval et al. demonstrat-
ed that UCP-2 siRNA increased mitochondria superoxide pro-
duction in murine endothelial cells [21]. It is possible that the
initial event after UCP-2 siRNA administration in our study is
increased mitochondrial superoxide production, leading to lipid
peroxidation and activation of ANT-mediated mitochondria
uncoupling. Remarkably, the compensatory ANT-mediated un-
coupling is more potent compared to the UCP-2-mediated
uncoupling in untreated diabetic animals, as evident from both
the lower mitochondrial membrane potential and the reduced
oxidative stress in the kidney of these animals. However, increased
mitochondria uncoupling results in increased mitochondrial O2
consumption. It should be noted that the normal kidney O2
consumption is high already during baseline conditions due to the
high metabolic demand for active tubular transport. This will be
further elevated in diabetes due to enhanced proximal transport
without a corresponding increase in blood flow [16], resulting in
tissue hypoxia throughout the diabetic kidney [8]. Kidney hypoxia
is strongly implicated as a common pathway for end-stage renal
disease [22] and it may be speculated that although a further
increased mitochondria uncoupling via the ANT results in lower
oxidative stress, the concomitantly increased O2 consumption will
accelerate kidney tissue hypoxia and development of diabetic
nephropathy.
In conclusion, the present study demonstrates that UCP-2 is
directly involved in regulating mitochondrial membrane potential
and therefore also is a potential mechanism to prevent excessive
mitochondria superoxide formation in the diabetic kidney.
Abolished UCP-2-mediated mitochondria uncoupling results in
an even more potent ANT-mediated uncoupling which reduces
membrane potential and oxidative stress damage in the diabetic
kidney. However, mitochondria uncoupling increases total O2
consumption and can potentially amplify the already existing
kidney tissue hypoxia in diabetes and therefore accelerate
development of diabetic nephropathy (Fig. 10).
Materials and Methods
Animal procedures
All animal procedures were carried out in accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Georgetown University Animal
Care and Use Committee (protocol number 07-125) and all efforts
were made to minimize suffering. All animals had free access to
standard rat chow and tap water. Diabetes was induced in male
Sprague Dawley rats (250–300 g) by intravenous injection of
streptozotocin (65 mg/kg bw dissolved in 0.2 ml saline) into the
Figure 9. Kidney tissue oxidative stress levels measured as TBARS in control and diabetic animals with and without scrambled or
UCP-2 siRNA.
doi:10.1371/journal.pone.0039635.g009
siRNA-Mediated Knockdown of UCP-2
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(MediSense, Bedford, MA, USA) in a blood sample obtained from
the cut tip of the tail and the animals were considered diabetic if
blood glucose levels increased $15 mM within 24 h of strepto-
zotocin administration, and remained elevated.
Under isoflouran anaesthesia (2% in 40% O2) a polyethylene
catheter was inserted into in the carotid artery and a non-
functional scrambled siRNA or siRNA targeting UCP-2 (100 mg/
rat; id nr 50931, Ambion, Austin, TX, USA, Table 2) was
administered in a total volume of 6 ml 37uC sterile saline during
6 seconds. The carotid artery was ligated and the wound closed.
siRNA was administered at day five of diabetes and all
experiments carried out two days thereafter.
Verification of successful UCP-2 knockdown using
western blot
Kidney cortex were homogenized in RIPA buffer (1% tergitol
type NP40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mmol/l
NaF, 80 mmol/l Tris, pH 7.5) with enzyme inhibitors (Phospha-
tase inhibitor cocktail-2; 10 ml/ml, Sigma-Aldrich, St Louis, MO,
USA and Complete Mini; 1 tablet/1.5 ml; Roche Diagnostics,
Mannheim, Germany) added fresh before each experiment.
Molecular weight separation was performed on 12.5% Tris-HCl
gels with Tris/glycine/SDS buffer, the proteins transferred to
nitrocellulose membranes and UCP-2 detected with goat anti-rat
UCP-2 (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and HRP-conjugated rabbit anti-goat (1:10,000; Kirkegaard
and Perry Laboratories, Gaithersburg, MD, USA). Luminescent
signal was captured on an ECL-camera system (Kodak image
station 2000; New Haven, CT). b-actin was detected with mouse
Figure 10. Summary of proposed mechanisms. Pathways highlighted in blue denote uncoupling via UCP-2; pathways highlighted in red
denote uncoupling via ANT. ANT – adenosine nucleotide transporter, CAT – carboxyatractylate, ETC – electron transport chain, FA
2 – charged fatty
acid, FA-H – uncharged fatty acid, GDP – guanosine diphosphate, UCP-2 – uncoupling protein 2.
doi:10.1371/journal.pone.0039635.g010
Table 2. Sequence of siRNA towards UCP-2 and scrambled
siRNA.
siRNA target Sequence (59-3 9)
Scramble (no known target) AAGCTTCATAAGGCGCATAGC
UCP-2 GGAGAGAGUCAAGGGUCAGtt
doi:10.1371/journal.pone.0039635.t002
siRNA-Mediated Knockdown of UCP-2
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USA) and secondary HRP-conjugated goat-anti mouse antibody
(1:60,000; Kirkegaard and Perry Laboratories, Gaithersburg, MD,
USA).
Mitochondria isolation and functional assessment
Under isoflourane anaesthesia (2% in 40% O2), a blood sample
was collected and frozen for later analysis of plasma malondialde-
hyde (MDA) and the kidneys excised and rapidly placed in ice-cold
buffer A (in mmol/l: 250 sucrose, 1 EGTA, 10 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), pH 7.4, 300 mOsm/kg
H2O). Isolation of kidney mitochondria were performed as
previously described [5]. In brief, kidney cortex was dissected
out on ice, rinsed with buffer A and homogenized in 10 ml of
buffer A on ice using a Potter-Elvehjem homogenizer (800 rpm).
The homogenate was transferred to pre-chilled centrifuge-tubes,
centrifuged at 8006g for 10 min at 4uC. The supernatants were
transferred to new tubes and centrifuged at 80006g for 10 min at
4uC. The pellets were gently resuspended in buffer A now
containing 1 mg/ml of bovine serum albumine (BSA, further
purified faction V, fatty acid free) and centrifuged at 80006g for
10 min at 4uC. The final pellet was dissolved in experimental
buffer (in mmol/l: 220 mannitol, 70 sucrose, 5 MgCl2, 5 KPO4
2,
10 HEPES, 0.048 sodium palmitate, 1 mg/ml fatty acid free BSA,
pH 7.4 and 330 mOsm/kg H2O).
Mitochondria O2 consumption was measured using a custom-
made gastight plexi-glass chamber with a total volume of 1.100 ml
thermostatically controlled to 37uC. The chamber was continu-
ously stirred with an air-driven magnetic stirrer. A modified
Unisense 500 O2 sensing electrode (Unisense, Aarhus, Denmark)
was calibrated with air-equilibrated buffer solution set to
228 mmol/l O2,N a 2S2O5-saturated buffer set to zero and rate
of O2 disappearance recorded. At the end of each experiment,
a sample was taken to determine the protein concentration using
DC Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA).
O2 consumption was calculated as the disappearance rate of O2
adjusted for protein concentration.
Addition of glutamate (10 mmol/l) and adenosine diphosphate
(ADP, 400 mmol/l) and subsequently calculated respiratory
control ratio (RCR; O2 consumption after ADP divided by O2
consumption after glutamate) was used as indication of functional
mitochondria. Any increased O2 consumption after addition of
glutamate to mitochondria pre-incubated with the ATP-synthase
inhibitor oligomycin (12 mg/mg protein) indicates O2 consump-
tion unrelated to ATP production and was used as an indicator of
mitochondrial uncoupling. This is referred to as glutamate-
stimulated O2 consumption. In separate experiments, ADP
(400 mmol/l), guanosine diphosphate (GDP; inhibitor of UCP
[13,23], 500 mmol/l) or CAT (inhibitor of ANT [10], 0.5 mmol/l)
was added in the presence of oligomycin and glutamate-stimulated
O2 consumption analysed. In experiments using CAT, the
mitochondria O2 consumption was recorded using the Oroboros
Oxygraph-2k (Oroboros Instruments, Innsbruck, Austria).
Mitochondria membrane potential
Mitochondria membrane potential was measured as uptake of
the flourofor tetramethylrhodamine methyl ester (TMRM) [24].
TMRM (0.35 mmol/l) was mixed with mitochondria experimental
buffer and fluorescence measured at excitation 546 nm and
emission 590 nm in a 384-well plate (GreinerBio One, Frick-
enhausen, Germany), and denoted total TMRM (TMRMT).
Mitochondria incubated with oligomycin and glutamate or with
coincubation of oligomycin, glutamate, GDP and CAT were
added to the wells, incubated for 5 min and pelleted at 80006g for
10 min at room temperature. The supernatant of each pellet was
analyzed for fluorescence (TMRM outside; TMRMO). Mitochon-
dria uptake of TMRM was calculated as TMRMT-TMRMO and
corrected for protein concentration.
ATP production by isolated mitochondria
Mitochondria ATP production was analyzed with a commer-
cially available bioluminescence assay from Molecular Probes
(ATP determination kit, A22066, Molecular Probes, Invitrogen,
Paisley, UK) according to manufacturer’s instruction. Analysis was
performed in four different settings: 1) mitochondria, glutamate
and ADP, 2) mitochondria, glutamate, ADP and carbonylcyanide-
p-trifluoromethoxyphenyl-hydrazone (FCCP), 3) mitochondria,
glutamate, ADP and oligomycin, and 4) mitochondria, glutamate,
ADP, oligomycin and CAT. Samples were incubated for 3 min at
37uC and thereafter snap frozen in liquid nitrogen. ATP
production was corrected for protein concentration and expressed
as mmol ATP/min/mg protein.
Thiobarbituric Acid Reactive Substances (TBARS) in
kidney cortex homogenate
TBARS was measured as previously describe [8]. In brief, 50 ml
cortex homogenate was added to 500 ml hydrochloric acid
(50 mmol/l), vortexed and 167 ml thiobarbituric acid (0.67%)
added. After incubation for 30 min at 95uC the samples were
cooled to room temperature and 667 ml methanol:n-butanol
added (3:17 mix, prepared fresh). The sample vortexed and
centrifuged at 2500 rpm for 20 min at 18uC. The top layer was
transferred to a transparent 384 well plate, analyzed for
absorbance at 535 nm and corrected for protein concentration.
Malondialdehyde (MDA) in plasma
Free plasma MDA was measured by HPCE-Micellar Electro-
kinetic Chromatography. Briefly, plasma was filtered through
a centrifugal filter with 3 kD cut-off. The ultrafiltrate was directly
injected into an uncoated fused silica capillary (75 micron ID,
length to detector 40 cm, total length 50.2 cm) on a Beckman
Coulter MDQ system (Fullerton, CA, USA) equipped with a UV
detector. A large volume stacking was used to introduce a large
plug of the sample hydrodynamically (0.5 psi, 20 seconds). The
background electrolyte solution contained sodium tetraborate
(25 mmol/l), spermine HCl (1 mmol/l), and tetradecyltrimethy-
lammonium bromide (TTAB; 2 mmol/l) at a pH of 9.7. UV
detection was carried out at 260 nm and Methyl MDA was used as
an internal standard. The separation was carried out at 212 kV
and 25uC. Intra-assay and inter-assay CV for this assay in samples
of plasma are 2.1% and 4.3% respectively and the limit of
detection is 0.1 mmol/l.
Statistical analysis
Statistical comparisons were made using one-way analysis of
variance (ANOVA) followed by Bonferroni’s multiple comparisons
test. Paired Student’s t-tests and repeated one-way ANOVA were
applied for comparisons within each group. A p,0.05 was
considered statistically significant and all values are presented as
mean6SEM.
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